Tag: preclinical
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.
-
Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.
-
Crispr Therapy Shown to Remove E. Coli in Gut
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics.
-
Low-Dose Covid-19 Vaccine Generates Strong Immune Response
Ultra-low quantities of an experimental Covid-19 protein vaccine delivered in synthetic cell components are shown in lab animals to generate strong immune responses.
-
Industry, Academic Labs Detailing ALS Treatment Actions
Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment.
-
Gene Therapy Shown to Build Knee Cartilage
Findings from research with lab animals shows a single gene therapy injection delivered with a benign virus helps build new knee cartilage cells and tissue.
-
Fox Foundation Funds New Genetic Variation Targets for Parkinson’s
A Parkinson’s disease organization is giving a grant to a neurodegenerative therapies developer that targets new groups of underlying disease-causing genetic changes.
-
Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-
mRNA Aerosol Delivered to Lungs to Treat Pneumonia
Messenger RNA, inhaled from an aerosol spray, is shown in lab rats with pneumonia to reduce inflammation, improve lung functions, and protect against further infections.